Status:
UNKNOWN
The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Respiratory Distress Syndrome
Eligibility:
All Genders
18-90 years
Brief Summary
Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able ...
Eligibility Criteria
Inclusion
- men and women;
- confirmed COVID19 diagnosis after nasal-oropharyngeal swab;
- any symptom at hospitalization
- any therapy
- any pre-existing comorbidity
Exclusion
- pregnant women
- healthy subjects with other respiratory diseases different from COVID-19
Key Trial Info
Start Date :
October 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 3 2021
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT04871685
Start Date
October 18 2020
End Date
May 3 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Campania Luigi Vanvitelli
Naples, Campania, Italy, 80138